These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 9251597

  • 1. Risk of relapse in leprosy after fixed-duration multidrug therapy.
    Li HY, Hu LF, Huang WB, Liu GC, Yuan LC, Jin Z, Li X, Li JL, Yang ZM.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597
    [Abstract] [Full Text] [Related]

  • 2. Fixed-duration multidrug therapy in multibacillary leprosy.
    Li HY, Hu LF, Wu PW, Luo JS, Liu XM.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596
    [Abstract] [Full Text] [Related]

  • 3. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
    Chen XS, Li WZ, Jiang C, Ye GY.
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
    [Abstract] [Full Text] [Related]

  • 4. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
    Chen XS, Li WZ, Jiang C, Ye GY.
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910
    [Abstract] [Full Text] [Related]

  • 5. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M, Marne RB, Varikkodan R, Bala N, Dandakeri S, Martis J.
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [Abstract] [Full Text] [Related]

  • 6. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
    Cellona RV, Balagon MF, dela Cruz EC, Burgos JA, Abalos RM, Walsh GP, Topolski R, Gelber RH, Walsh DS.
    Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A, Nadkarni NJ, Kini MS, Mehta VR.
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A study of relapse after MDT in a district in West Bengal, India.
    Haldar A, Mahapatra BS, Mundle M, Haldar S, Saha AK.
    Indian J Lepr; 2003 Mar; 75(1):1-8. PubMed ID: 15253389
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fixed-duration therapy (FDT) in multibacillary leprosy; efficacy and complications.
    Vijayakumaran P, Jesudasan K, Manimozhi N.
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):123-7. PubMed ID: 8690969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.